Genmab Competitors and Similar CompaniesClear all
Genmab's competitors and similar companies include CSL Behring, Biogen and Genentech.
 Genmab Genmab is a biotechnology company that develops and commercializes antibody therapeutics to treat cancer. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 1999 | Founding Date 1904 | Founding Date 1978 | Founding Date 1976 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Copenhagen, DK HQ Tokyo, JP Utrecht, NL Plainsboro, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 2,638 | Employees 7,5692% decrease | Employees 7,605 | Employees 18,077 |
Valuation ($) | Valuation ($) 14.7 b | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $221m (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $3.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income $963m (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products 28 (Jul, 2025) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products 19 (Jul, 2025) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products 41 (Jul, 2025) |
Trademarks | Trademarks 285 (FY, 2018) | Trademarks 4 (Dec, 2020) | Trademarks N/A | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company